Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
71.46
-0.26 (-0.36%)
At close: Apr 2, 2026, 4:00 PM EDT
72.88
+1.42 (1.99%)
After-hours: Apr 2, 2026, 7:48 PM EDT
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of $689 million as of April 2, 2026. Its market cap has increased by 152.85% in one year.
Market Cap
689.00M
Enterprise Value
625.08M
1-Year Change
152.85%
Ranking
Category
Stock Price
$71.46
Market Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from $41.78M to $689.00M, an increase of 1,548.99%. That is a compound annual growth rate of 72.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 689.00M | 9.86% |
| Dec 31, 2025 | 627.18M | 150.23% |
| Dec 31, 2024 | 250.64M | 3,397.75% |
| Dec 29, 2023 | 7.17M | -49.18% |
| Dec 30, 2022 | 14.10M | -63.08% |
| Dec 31, 2021 | 38.19M | -8.59% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MeiraGTx Holdings | 740.35M |
| Maravai LifeSciences Holdings | 737.78M |
| Kura Oncology | 736.67M |
| Solid Biosciences | 726.13M |
| Arvinas | 724.68M |
| BridgeBio Oncology Therapeutics | 722.70M |
| Vor Biopharma | 722.03M |
| Lexicon Pharmaceuticals | 694.84M |